SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-16-156955
Filing Date
2016-11-14
Accepted
2016-11-14 16:58:58
Documents
3
Group Members
LINDEN CAPITAL L.P.LINDEN GP LLCSIU MIN WONG

Document Format Files

Seq Description Document Type Size
1 SC 13D a16-21575_1sc13d.htm SC 13D 144559
2 EX-99.A a16-21575_1ex99da.htm EX-99.A 17175
3 EX-99.B a16-21575_1ex99db.htm EX-99.B 1921
  Complete submission text file 0001104659-16-156955.txt   165294
Mailing Address 590 MADISON AVENUE, 15TH FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE, 15TH FLOOR NEW YORK NY 10022 646-840-3500
LINDEN ADVISORS LP (Filed by) CIK: 0001279396 (see all company filings)

IRS No.: 830356741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 343 PHOENIXVILLE PIKE MALVERN PA 19355
Business Address 343 PHOENIXVILLE PIKE MALVERN PA 19355 610-889-9900
TETRALOGIC PHARMACEUTICALS CORP (Subject) CIK: 0001361248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87773 | Film No.: 161995758
SIC: 2834 Pharmaceutical Preparations